Takeaways From the Big Long COVID Clinical Trials

Takeaways From the Big Long COVID Clinical Trials

by | Apr 21, 2026 | Amytriptyline, Antivirals, CoQ10, COVID-19, Homepage, Inflammation, Ivabradine, Klimas, Lipids, long COVID, Mast cell activation syndrome, Microbiome, Orthostatic intolerance, Paxlovid, POTS, Treatment

Only 10 major long COVID clinical trials have been published thus far but that's enough to come away with some interesting takeaways. They include treatments that prevent long COVID don't necessarily treat it, broader based treatments are probably best, manipulating the gut can help with fatigue (but only so much), and an as yet unassessed class of drugs may be helpful.
Explorations #2: The RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide

Explorations #2: The RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide

by | Apr 6, 2026 | Abilify, Antivirals, Baricitinib, Bezisterim, CCR5 Antagonists, Drugs, GLP-1, Guanfacine, Homepage, Ivabradine, IVIG, JAK_STAT Inhibitors, Low Dose Naltrexone, Mestinon, Rapamycin, Stellate Ganglion Block, Stimulants, Trazodone, Treatment

Check out the The free RTHM and Patient-Led Research Collaborative Long COVID Treatment Guide and why we may FDA approved drugs for long COVID quicker than you might think.
Low Brain Norepinephrine Levels in ME/CFS and Long COVID Pt. II: A ChatGPT Based Treatment Program

Low Brain Norepinephrine Levels in ME/CFS and Long COVID Pt. II: A ChatGPT Based Treatment Program

by | Nov 16, 2025 | Autonomic Nervous System, Brain, Brainstem, Clonidine, CoQ10, D-Ribose, GLP-1, GLP-1 agonist, Guanfacine, Homepage, Ivabradine, Kaiser, L-carntine/Acetylcarnitine, Locus coeruleus, Mast cell activation syndrome, Mestinon, Neuroplasticity, Neuroplasticity, Norepinephrine, Pacing, Prefrontal Cortex, Propanolol, Rapamycin, Research, Stimulants, Urolithin A

Check out how ChatGPT thinks people with ME/CFS and long COVID might treat the low norepinephine brain findings in these diseases.
“The OI Guy”: Peter Rowe MD on “Living Well with Orthostatic Intolerance” in ME/CFS, POTS and Long COVID: A Book Review and Talk

“The OI Guy”: Peter Rowe MD on “Living Well with Orthostatic Intolerance” in ME/CFS, POTS and Long COVID: A Book Review and Talk

by | Oct 5, 2024 | Amytriptyline, Cervical Stenosis, Connective Tissues, Craniocervical Instability, Ehlers Danlos Syndrome, Endometriosis, Homepage, Ivabradine, Mast cell activation syndrome, Orthostatic intolerance, Pathogens, POTS, Propanolol, Rowe, Stimulants

Dr. Peter Rowe talks about his new book on orthostatic intolerance and how treating it can help people with chronic fatigue syndrome (ME/CFS), POTS, Long COVID, chronic pelvic pain and other conditions.
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest